Skandinaviska Enskilda Banken Ab (Publ) Fulgent Genetics, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$47.98 - $62.75 $4.61 Million - $6.03 Million	-96,099 Reduced 71.26%	38,750 $2.11 Million
Q1 2022 May 11, 2022	SELL	$49.85 - $96.11 $7.18 Million - $13.8 Million	-144,026 Reduced 51.65%	134,849 $8.42 Million
Q4 2021 Feb 10, 2022	BUY	$77.3 - $105.0 $20 Million - $27.2 Million	258,700 Added 1282.28%	278,875 $28.3 Million
Q3 2021 Nov 10, 2021	SELL	$74.87 - $110.87 $8.56 Million - $12.7 Million	-114,335 Reduced 85.0%	20,175 $1.82 Million
Q2 2021 Aug 10, 2021	BUY	$66.8 - $100.45 $3.71 Million - $5.58 Million	55,594 Added 70.45%	134,510 $12.4 Million
Q1 2021 May 14, 2021	BUY	$59.3 - $183.85 $2.63 Million - $8.15 Million	44,348 Added 128.29%	78,916 $7.63 Million
Q4 2020 Feb 11, 2021	BUY	$31.01 - $52.1 $1.07 Million - $1.8 Million	34,568 New	34,568 $1.8 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.